Simplex Trading’s Synageva Biopharma GEVA Stock Holding History
Bought
Maintained
Sold
Simplex Trading's GEVA Position: Q1 2015 in Review
Simplex Trading sold out of Synageva Biopharma (GEVA) in Q1 2015, closing a stake of 6,989 shares — an estimated $740K sold.
Simplex Trading first reported a position in GEVA in Q4 2014 and held it in 1 quarter. The position peaked at $649K in Q4 2014. 130 funds tracked by Wall St. Rank hold GEVA as of Q1 2015.
- Simplex Trading reported no remaining Synageva Biopharma position as of Q1 2015 after selling out during the quarter.
- Simplex Trading sold 6,989 Synageva Biopharma shares in Q1 2015, an estimated $740K.
- Simplex Trading first reported a position in Synageva Biopharma in Q4 2014 and held it in 1 quarter.
- Simplex Trading's Synageva Biopharma position peaked at $649K in Q4 2014.
- 130 funds tracked by Wall St. Rank held Synageva Biopharma as of Q1 2015.
Based on Simplex Trading's 13F filing for Q1 2015, filed 21 Apr 2015.